
b-rayZ is at the forefront of breast imaging technology, offering state-of-the-art AI and Swiss medical expertise to improve early breast cancer detection and patient outcomes. Their modular end-to-end platform supports women through the entire diagnostic journey, providing real-time results and automatic classifications. With a focus on personalized care, b-rayZ aims to revolutionize women's healthcare by leveraging advanced AI algorithms to enhance diagnostic accuracy and treatment outcomes. The company has achieved significant milestones, including CE certifications and partnerships, positioning itself as a leader in the breast imaging market.

b-rayZ is at the forefront of breast imaging technology, offering state-of-the-art AI and Swiss medical expertise to improve early breast cancer detection and patient outcomes. Their modular end-to-end platform supports women through the entire diagnostic journey, providing real-time results and automatic classifications. With a focus on personalized care, b-rayZ aims to revolutionize women's healthcare by leveraging advanced AI algorithms to enhance diagnostic accuracy and treatment outcomes. The company has achieved significant milestones, including CE certifications and partnerships, positioning itself as a leader in the breast imaging market.
Founded: 2019
Headquarters: Zürich, Switzerland
Product: AI software for breast imaging quality management and diagnostic standardization
Employee count (est.): 11–50
Total funding reported: 4,290,000 USD
Breast imaging quality, diagnostic standardization, and early breast cancer detection
2019
Medtech / Healthtech
Series A announced Jun 30, 2025
Series A announced Jul 7, 2022; other investors listed for that round include LifeCare Partners and Convergence Partners AG